Neostigmine [neostigmin]
- Terms
-
neostigmin-bromid
neostigmin-methylsulfát
neostigminbromid
neostigminmethylsulfát
Syntostigmin
-
Neostigmine Bromide
Neostigmine Methylsulfate
Polstigmine
Proserine
Prostigmin
Prostigmine
Prozerin
Synstigmin
Syntostigmine
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
- DUI
- D009388 MeSH Browser
- CUI
- M0014615
- CAS
- Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
Allowable subheadings
- AD
- administration & dosage 12
- AE
- adverse effects 7
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history 1
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 2
- PD
- pharmacology 14
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 23
- TO
- toxicity 2
- UR
- urine